Influenza A and Secondary Bacterial Infections: Pathogenesis, Clinical Outcomes, and Preventive Strategies

Abstract

Influenza A virus (IAV) is a significant global health concern, leading to seasonal epidemics and pandemics. While primary viral infections are often self-limiting, they predispose individuals to secondary bacterial infections, which can exacerbate morbidity and mortality. This narrative review explores the interplay between IAV and secondary bacterial infections, focusing on their pathogenesis, clinical impact, and strategies for prevention and management, with the objective of informing real-world implementation efforts. Secondary bacterial pathogens, such as Streptococcus pneumoniae , Staphylococcus aureus , and Haemophilus influenzae , are commonly implicated in these co-infections. The synergistic effects of IAV and bacterial pathogens complicate the clinical course, leading to severe outcomes, including pneumonia and sepsis.